A Prospective Biopsychosocial Repeated Measures Study of Stress and Dropout from Substance Addiction Treatment

Overview

Journal Subst Abuse Rehabil

Publisher Dove Medical Press

Specialty Psychiatry

Date 2023 Jul 19

PMID 37465017

Authors

Kari Bohle

Eli Otterholt

Stal Kapsto Bjorkly

Affiliations

Soon will be listed here.

Abstract

Introduction: This prospective, repeated-measures observational study tested biopsychosocial variables as risk factors for dropping out of inpatient substance addiction treatment. Substance use disorder (SUD) is viewed as a chronic relapsing disease caused by an interaction between biological, psychological, and social factors. However, there is a lack of prospective studies that combine biopsychosocial variables when assessing dropout. The aims of this study were to investigate whether there was 1) An association between biopsychosocial factors and dropping out of inpatient substance addiction treatment, 2) An interaction with SUD diagnosis and cortisol, and 3) Different dropout rates between short-term and long-term institutions.

Materials And Methods: Patients (n = 173) were recruited from two inpatient treatment centers in Norway between 2018 and 2021. The following biopsychosocial variables were measured at four timepoints: ward atmosphere (Ward Atmosphere Scale, WAS), psychological distress (Hopkins Symptom Checklist 10, HSCL-10), motivation (M-scale of the Circumstances, Motivation, Readiness, and Suitability questionnaire), and concentration of salivary cortisol (CORT- nmol/L). Cortisol levels were measured for two consecutive days at each timepoint and calculated by two cortisol indices, daytime cortisol slope (DCS) and area under the curve with respect to the ground (AUC). A multivariate logistic regression analysis was performed to find an association between dropout rates and the biopsychosocial variables.

Results: The results suggest a lower dropout odds for patients with high motivation (OR = 0.76, p = 0.022) and patients admitted to short-term treatment (OR = 0.06, p = 0.005). An interaction with stimulant SUD and DCS (OR = 13.74, p = 0.024) also revealed higher dropout odds. No statistical significance was found for psychological distress, WAS, and cortisol AUC.

Conclusion: The results support monitoring motivation during treatment and further investigating biopsychosocial variables when assessing dropout risk together with SUD diagnosis.

Citing Articles

The Implementation of the Biopsychosocial Model: Individuals With Alcohol Use Disorder and Post-Traumatic Stress Disorder.

Hinostroza F, Mahr M Brain Behav. 2024; 15(1):e70230.

PMID: 39740784 PMC: 11688116. DOI: 10.1002/brb3.70230.

References

Darke S, Campbell G, Popple G . Retention, early dropout and treatment completion among therapeutic community admissions. Drug Alcohol Rev. 2011; 31(1):64-71. DOI: 10.1111/j.1465-3362.2011.00298.x. View

Landheim A, Bakken K, Vaglum P . Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties. BMC Psychiatry. 2006; 6:44. PMC: 1626456. DOI: 10.1186/1471-244X-6-44. View

Shoham E, Efodi R, Haviv N, Gross Shader C . Dropout from Treatment and Desistance from Crime among Released Prisoners in Jerusalem Halfway House for Prisoners with Substance Misuse Disorder. Int J Offender Ther Comp Criminol. 2021; 66(10-11):1109-1133. DOI: 10.1177/0306624X211010291. View

Adam E, Kumari M . Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009; 34(10):1423-36. DOI: 10.1016/j.psyneuen.2009.06.011. View

Ali B, Green K, Daughters S, Lejuez C . Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention. Addict Behav. 2017; 73:99-104. PMC: 5542844. DOI: 10.1016/j.addbeh.2017.04.016. View

Philips B, Wennberg P . The importance of therapy motivation for patients with substance use disorders. Psychotherapy (Chic). 2013; 51(4):555-562. DOI: 10.1037/a0033360. View

Strand B, Dalgard O, Tambs K, Rognerud M . Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry. 2003; 57(2):113-8. DOI: 10.1080/08039480310000932. View

Wemm S, Sinha R . Drug-induced stress responses and addiction risk and relapse. Neurobiol Stress. 2019; 10:100148. PMC: 6430516. DOI: 10.1016/j.ynstr.2019.100148. View

Andersson H, Otterholt E, Grawe R . Patient satisfaction with treatments and outcomes in residential addiction institutions. Nordisk Alkohol Nark. 2020; 34(5):375-384. PMC: 7450857. DOI: 10.1177/1455072517718456. View

10.

Ligabue K, Schuch J, Scherer J, Ornell F, Roglio V, Assuncao V . Increased cortisol levels are associated with low treatment retention in crack cocaine users. Addict Behav. 2020; 103:106260. DOI: 10.1016/j.addbeh.2019.106260. View

11.

Cuttler C, Spradlin A, Nusbaum A, Whitney P, Hinson J, McLaughlin R . Blunted stress reactivity in chronic cannabis users. Psychopharmacology (Berl). 2017; 234(15):2299-2309. DOI: 10.1007/s00213-017-4648-z. View

12.

Magill M, Ray L . Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009; 70(4):516-27. PMC: 2696292. DOI: 10.15288/jsad.2009.70.516. View

13.

Rao U, Hammen C, Poland R . Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity. Am J Psychiatry. 2009; 166(3):361-9. PMC: 2770585. DOI: 10.1176/appi.ajp.2008.08030412. View

14.

Koob G, Kreek M . Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007; 164(8):1149-59. PMC: 2837343. DOI: 10.1176/appi.ajp.2007.05030503. View

15.

SIMPSON D, Joe G, Greener J . Drug abuse treatment process components that improve retention. J Subst Abuse Treat. 1998; 14(6):565-72. DOI: 10.1016/s0740-5472(97)00181-5. View

16.

Taxman F, Thanner M, Weisburd D . Risk, Need, And Responsivity (RNR): It All Depends. Crime Delinq. 2008; 52(1):28-51. PMC: 2423325. DOI: 10.1177/0011128705281754. View

17.

Winhusen T, Kropp F, Babcock D, Hague D, Erickson S, Renz C . Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat. 2007; 35(2):161-73. PMC: 2546520. DOI: 10.1016/j.jsat.2007.09.006. View

18.

Daughters S, Lejuez C, Bornovalova M, Kahler C, Strong D, Brown R . Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. J Abnorm Psychol. 2005; 114(4):729-34. DOI: 10.1037/0021-843X.114.4.729. View

19.

Carr W, Ball S . Predictors and treatment outcomes of perceived ward atmosphere among therapeutic community residents. J Subst Abuse Treat. 2014; 46(5):567-73. DOI: 10.1016/j.jsat.2014.01.003. View

20.

Pruessner J, Kirschbaum C, Meinlschmid G, Hellhammer D . Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003; 28(7):916-31. DOI: 10.1016/s0306-4530(02)00108-7. View